BioLine Rx Newsroom

JonesTrading Maintains BioLine Rx(BLRX.US) With Buy Rating, Maintains Target Price $2

Futu NewsNov 27 02:31

JonesTrading Reaffirms Their Buy Rating on Bioline RX Ltd Sponsored ADR (BLRX)

TipRanksNov 27 01:49

HC Wainwright & Co. Maintains Buy on BioLine Rx, Lowers Price Target to $9

BenzingaNov 26 01:14

BioLine Rx Analyst Ratings

BenzingaNov 26 01:13

BioLine RX Price Target Maintained With a $21.00/Share by HC Wainwright & Co.

Dow JonesNov 6 20:55

BioLine Rx Analyst Ratings

BenzingaSep 5 00:07

JonesTrading Initiates BioLineRx at Buy With $2 Price Target

MT NewswiresSep 4 19:48

JonesTrading Initiates BioLine Rx(BLRX.US) With Buy Rating, Announces Target Price $2

Futu NewsSep 4 04:31

BioLine Rx Analyst Ratings

BenzingaJun 4 00:40

BioLine Rx Analyst Ratings

BenzingaMay 29 22:25

HC Wainwright & Co. Reiterates Buy on BioLine Rx, Maintains $21 Price Target

BenzingaMay 29 22:25

HC Wainwright & Co. : The BioLine Rx (BLRX.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $21.00.

Zhitong FinanceApr 18 01:40

BioLine Rx Analyst Ratings

BenzingaApr 18 01:35

Buy Rating on Bioline RX Ltd for Breakthrough Stem Cell Mobilization and Enhanced Apheresis Efficiency

TipRanksApr 17 23:10

BioLine Rx Analyst Ratings

BenzingaMar 27 00:15

BioLine Rx Analyst Ratings

BenzingaMar 1 04:34

Positive Outlook for Bioline RX With Promising Phase 2 Trial Results and New Product Launch: A Buy Rating

TipRanksFeb 29 19:27

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Bioline RX Ltd Sponsored ADR (BLRX) and Arrowhead Pharmaceuticals (ARWR)

TipRanksDec 22, 2023 00:11

HC Wainwright & Co. Reiterates Buy on BioLine Rx, Maintains $21 Price Target

BenzingaNov 21, 2023 01:37

BioLine Rx Analyst Ratings

BenzingaNov 21, 2023 01:36